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In the last decade, two main strategies have been employed in the prevention of catheter-
related infections: the creation of anti-adhesive biomaterials using physicochemical
methods, and the incorporation of antimicrobial or antiseptic agents into current polymer
biomaterials. There has been limited success with the first approach. Intravascular
catheters and cuffs with an antimicrobial coating have been developed in recent years.
Nevertheless, preventive strategies should avoid the use of therapeutic antibiotics.
Exposure to antimicrobial agents could favor the development of resistance or the
expression of genes responsible for biofilm formation. The use of these catheters should
be restricted to situations where the rate of infection is high despite adherence to other
strategies that do not incorporate antimicrobial agents. Better knowledge of the patho-
genesis of catheter-related infections will facilitate the design of new devices that avoid
the use of antimicrobial agents and decrease the risk of associated bloodstream infections.
This could include the use of ‘biospecific polymers’ coated with anti-adhesive molecules
or the use of agents which might block the expression of genes controlling biofilm
formation for the most prevalent pathogens.
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Independent of the source of microorganisms colo-
nizing intravascular catheters, many factors have
been shown to affect the risk of catheters becoming
infected. These include the unique capability that
some microorganisms have of causing catheter-
related infections. In fact, a series of interactions
takes place between microorganism, biomaterial
and host that determines the development of infec-
tion. A fourth relevant factor is the antimicrobial
agent that develops its activity against sessile
bacteria by forming a biofilm. The purpose of this
review is to describe the interaction among these
four essential factors in the development of cathe-
ter-related infections.
S O U R C E S O F M I C R O O R G A N I S M S
The routes by which bacteria reach the surface of
intravenous devices have remained constant [1]
over time. In the short term (<8 days), catheters are
colonized by skin microorganisms (70–90%), fol-
lowed by bacteria from the hub/lumen (10–50%),
the bloodstream (3–10%) and infusate (< 3%). In
the case of long-term catheters (> 8 days), the most
frequent source of colonization is the hub [2,3],
followed by the skin [2]. Staphylococcus aureus and
Staphylococcus epidermidis are the microorganisms
most frequently involved in catheter-related infec-
tions.
B A C T E R I A – B I O M A T E R I A L
I N T E R A C T I O N
The probability of bacterial adhesion is dependent
on the surface characteristics of the plastic bioma-
terial and the microorganism, while the kinetics of
the process are affected by environmental factors.
The initial bacterial adhesion depends on long-
range bacteria–biomaterial surface interactions,
including van der Waals forces, electrostatic inter-
actions and hydrophobic interactions [3,4]. These
forces also affect protein adhesion on the surface of
the biomaterial. The correlation between bacterial
hydrophobicity and adhesion to hydrophobic bio-
materials has been demonstrated for S. epidermidis,
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the most frequent bacterium causing this type of
infection (Figure 1) [3].
The adherence of a hydrophobic strain of S.
epidermidis to teflon catheters is significantly grea-
ter than that of a hydrophilic strain (Figure 2).
Similar results were obtained when several strains
with different hydrophobicity values were tested
[4]. Moreover, most plastic biomaterials com-
monly used to make intravascular devices are
hydrophobic, thus facilitating the initial attach-
ment of bacteria.
Many bacteria also have hydrophobic compo-
nents at their surface. When two hydrophobic
surfaces interact in an aqueous environment, they
tend to become attached by removing the water
molecules between them. This initial bacterial
adhesion, which is non-specific and reversible, is
followed by a specific adhesion, mediated by an
adhesin receptor, which strongly fixes the micro-
organisms to the surface of the biomaterial [5].
Staphylococci express specific adhesins on their
surface which can recognize some major extracel-
lular host proteins. Host proteins able to promote
the adherence of S. aureus include protein and
glycoprotein components from plasma and con-
nective tissue. Of these, the most important gly-
coprotein is fibronectin, followed by fibrinogen
and fibrin [6]. Collagen, laminin, vitronectin, elas-
tin and von Willebrand factors have also been
involved [6]. Fibronectin is a large multidomain
glycoprotein which can be found, in soluble form,
in blood and other body fluids or, in insoluble
form, in connective tissues and cell surfaces.
In contrast, coagulase-negative staphylococci,
particularly S. epidermidis, exhibit weaker interac-
tions with host proteins, and seem to have a lower
number of adhesins. While the adherence of S.
aureus is stimulated by protein-coated polymers,
the adherence of S. epidermidis to plastic biomater-
ials depends more on hydrophobic interaction and
is usually impaired by plasma proteins [7].
The adherence of S. aureus to fibrinogen is medi-
ated by a fibrinogen-binding protein (FBe) [8]. The
Fbe gene is only expressed in a few S. epidermidis
strains [9]. The site of S. aureus recognition on fib-
ronectin is located in the N-terminal half of the
protein. This binding domain is close to a heparin
domain of fibronectin, leading to the inhibition of
Figure 1 Factors involved in the colonization of a plastic
biomaterial by S. epidermidis.
Figure 2 In vitro adherence of a
hydrophobic and a hydrophilic S.
epidermidis strain to teflon catheters.
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the interaction with bacteria in the presence of
heparin [9].
The role of fibronectin in S. epidermidis adher-
ence is controversial. Some authors postulate that
fibronectin mediates S. epidermidis attachment,
although the adhesin involved is currently
unknown. In our experience, fibronectin-coated
catheters did not increase the adherence of S.
epidermidis in vitro [4].
During the course of polymer colonization, S.
epidermidis and other staphylococci produce large
amounts of extracellular slime in which cells are
embedded and covered. This slimy substance pro-
tects bacteria against host defense mechanisms
and antimicrobial agents [10]. Many other biolo-
gical activities have been attributed to slime [11].
Slime is an extensive and diffuse polyanionic
matrix that surrounds the cells [10]. The composi-
tion of slime is controversial.
Early studies purified a substance that was
contaminated with components of the medium
and led to false results [7]. Several studies have
tried to elucidate the real composition of slime.
Probably, what have been called variously, ‘cap-
sular polysaccharide adhesin’ (PS/A) [12], ‘slime-
associated antigen’ (SAA) [13] and ‘polysaccharide
intracellular adhesin’ (PIA) are in fact the same
substance [7].
The most important study on the composition of
slime was published by Mack et al. [14]. This
substance, which is composed of two polysacchar-
ide fractions I and II, is referred to as PIA. The core
polymer of PIA has a 9 1,6-linked N-acetylgluco-
samine structure [7]. PIA expression is mediated
by the ica gene [15]. It has been shown that S.
epidermidis strains expressing PIA had 3–10-fold
increased capability for biofilm formation.
Recent studies suggest that a relevant factor in
biofilm formation is a phenomenon called quorum
sensing [16]. This is a cell-to-cell communica-
tion device used by bacteria to regulate different
processes, including biofilm formation. Quorum
sensing has been shown to occur in vivo on urinary
catheters with Pseudomonas aeruginosa [17]. A dee-
per knowledge of this process in vascular catheter
infection may lead to new strategies for preventing
it.
An ongoing question is whether there is any
correlation between catheter-related infection and
catheter-related thrombosis. It has been shown
that heparin-coated central venous catheters lead
to reductions in both catheter-related thrombosis
and catheter-related infection [18]. Heparin is
attached to the catheter via benzalkonium chlor-
ide, a substance that shows antibacterial activity
and may be responsible for the lower risk of
infection. Whether the heparin or the benzalko-
nium chloride is responsible for the reduced risk of
thrombosis remains to be evaluated [19].
The nature and chemical composition of the
biomaterials commonly used to make medical
devices differ, and many of them contain different
additives and plasticizers to improve their physi-
cochemical properties and biocompatibility.
The adherence of different microorganisms to,
and their survival in, catheters is promoted not
only by bacterial factors, but also by bacterium–
device interactions [20]. It has been proposed that
some microorganisms, such as coagulase-negative
staphylococci, could metabolize some of the com-
ponents of plastic catheters in the absence of other
nutrients and use them to sustain growth on the
surface of the biomaterial [21].
We evaluated the kinetics of adherence of
different microorganisms to catheters made of
polyvinyl chloride (PVC), teflon, siliconized latex,
polyurethane and Vialon [21–23]. Bacterial adher-
ence to PVC and siliconized latex was significantly
higher than adherence to the other biomaterials for
all the strains tested (Table 1). Lowest adherence
values were observed with polyurethanes for
the staphylococci. Bacterial viability and growth
Table 1 Maximum levels of bacterial adherence to plastic catheters during incubation for 72 h (modified from [21])
Mean (SD) number of adherent bacteria 103/cm2
Catheter S. aureus S. epidermidis Escherichia coli P. aeruginosa
Siliconized latex 27 (3) 18 (2) 19 (2) 24 (3)
PVC 42 (5) 23 (3) 18 (2) 41 (4)
Teflon 11 (1) 7 (0.4) 3 (0.1) 10 (1)
Polyurethane 15 (1) 4 (0.6) 9 (0.5) 13 (1)
Vialon 7 (1) 5 (0.3) 4 (0.2) 11 (1)
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were evaluated in eluates obtained from the
incubation of segments of each catheter in buffer
for 24 h. None of the eluates affected the viability of
the staphylococci. However, all of them sig-
nificantly increased the growth of Escherichia coli
and P. aeruginosa (Table 2). Bacterial adherence to
catheters may depend, in part, on the nature of the
biomaterial, and some substances eluted from the
catheter may affect the viability and growth of
different microorganisms [21].
B I O M A T E R I A L – H O S T D E F E N S E
M E C H A N I S M I N T E R A C T I O N
Adhesion of bacteria to a catheter surface is a
critical step in the development of catheter-
associated infection. Persistence of the adherent
bacteria is essential for colonization and biofilm
formation. A significant factor in this persistence is
depressed immunity induced by the presence of
the device. Both the complement system and poly-
morphonuclear leukocyte (PMN) activity may be
affected by the presence of an implanted device
[6]. Activation of the complement system by a
plastic biomaterial generally occurs via the alter-
native pathway.
The capacity to activate complement depends
upon the properties of the surface. Initiation of the
complement cascade may result in the activation
of leukocytes [6]. Activation of leukocytes is also
mediated by the adhesion of the biomaterial. Initial
activation in response to the biomaterial is fol-
lowed by the depression of leukocyte functions
(chemotaxis, uptake, microbicidal mechanisms)
and a state of refractoriness with respect to other
stimuli.
We evaluated the effect of five types of plastic
biomaterials (polyvinyl chloride, teflon, polyur-
ethane, Vialon and siliconized latex) on the pha-
gocytic and bactericidal functions of human PMN
[24]. Superoxide radical production by PMN was
significantly inhibited in the presence of PVC,
teflon and siliconized latex (Table 3).
The effect of siliconized latex was presumably
mediated by products eluted from the catheter into
the medium, since the incubation of PMN in elu-
ates, obtained from the incubation of this catheter
in buffer, induced a similar inhibitory effect. This
phenomenon was not observed with polyur-
ethanes. None of the catheters affected the uptake
of S. aureus by human PMN.
A N T I M I C R O B I A L A G E N T S W I T H
A C T I V I T Y A G A I N S T B I O F I L M -
P R O D U C I N G B A C T E R I A
Many research groups have investigated the
potential of antimicrobial agents to prevent biofilm
formation or to cure catheter-related infection [7].
Little attention has been paid, however, to the
effect of biomaterials or their components on the
activity of antibiotics against bacteria. We observed
that MICs of amikacin and carbapenem against P.
aeruginosa increased at least 4-fold and 16-fold,
respectively, in the presence of siliconized latex,
a biomaterial commonly used to make urinary
Table 3 Superoxide production of PMN after incubation
for 30 min in the presence of different catheters
nmol superoxide
radicals/mg protein
Catheter PMA Zymosan
None (control) 196 86
Siliconized latex 62 32
PVC 104 50
Teflon 127 51
Polyurethane 180 87
Vialon 167 80
Table 2 Growth of bacteria in eluates from different catheters in PBS
Mean (SD) CFU 104/mL
Catheter S. aureus S. epidermidis Escherichia coli P. aeruginosa
None 0.1 0.6 1.5 600
Siliconized latex 0.2 0.5 0 1150
PVC 0.2 0.2 11 3150
Teflon 0.2 0.1 160 2980
Polyurethane 0.2 0.6 250 3250
Vialon 0.2 0.4 60 3506
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catheters [25]. This effect was not strain-dependent
and was similar for different branches of catheters.
In fact, this phenomenon was induced by sub-
stances eluted from the biomaterials [25].
These substances did not inactivate carbape-
nems or increase b-lactamase activity [26]. The
outer membrane of P. aeruginosa grown in the
presence of the biomaterial lacked an OprD-like
protein and expressed a new 50-kDa protein.
The substance involved in this effect is currently
under investigation [26]. The clinical importance
of these findings is unknown but, assuming that
the concentrations of substances eluted from this
biomaterial are high in the microenvironment of
the bacterial biofilm, we may suppose that it is
an advantageous situation for P. aeruginosa to be
attached to this biomaterial, because of its ability to
grow using the eluate as a nutrient and to evade
the activity of some antimicrobial agents [26].
S. epidermidis is an important cause of infection
in patients with intravascular catheters. Treatment
of these infections often includes the removal of
the device, since a cure cannot usually be effected
by antimicrobial therapy alone.
S. epidermidis grows on the surface of plastic
catheters, forming bacterial biofilms that hinder
the activity of most antimicrobial agents. It has
been reported that bacterial biofilms on plastic
surfaces are more resistant to antimicrobial agents
than are planktonic bacteria. We evaluated the
activity of different antimicrobial agents against
bacterial biofilms produced by slime-producing
and non-slime-producing S. epidermidis strains
on teflon catheters [27]. The increase in MBC
values when sessile and planktonic bacteria were
compared is shown in Table 4. The MBC values of
amikacin, clindamycin, cloxacillin, ciprofloxacin,
vancomycin, daptomycin and rifampin were 32–
32.768 times greater when bacterial biofilms were
used as inoculum for both strains.
At high concentrations (16MBC), none of
these agents was able to sterilize the surface of
the catheters. Cloxacillin and quinolone induced
the greatest reduction in bacterial viability [28,29].
Previous reports have demonstrated differences
in interaction between bacteria and different bio-
materials [30]. The responses of bacterial biofilms
developed on the surface of several biomaterials to
antimicrobials may in fact be different. We eval-
uated the susceptibility of S. epidermidis attached to
two different polyurethane catheters [30]. MBCs
markedly increased in the presence of 6- and 48-h
bacterial biofilms. These increases in MBC values
occurred when either slime-producing or non-
slime-producing strains were used and, in most
cases, were much higher for one catheter than for
the other (Table 5). This phenomenon was shown
not to be due to differences in bacterial adherence.
The activity of certain antimicrobials decreases
markedly when bacteria are attached to plastic
catheters, but this effect may have been partly
dependent on the nature of the catheters [29].
Since single-antibiotic therapy has little effect in
curing biofilm-associated infections, combinations
of different antibiotics have been tested. Antibio-
tics in the cell wall-active class, such as glycopep-
tides, are synergistic with rifampin, completing the
bactericidal action [7]. For treatment of implant-
associated infections, therefore, a combination of
vancomycin and rifampin has been successfully
used. This was corroborated in another study,
where biofilm infection was never cured by van-
comycin alone and where the highest cure rate was
achieved with a combination of vancomycin and
rifampin [31]. We evaluated the in vitro activity of
vancomycin and teicoplanin (4MBC), both alone
and in combination with amikacin (16 mg/L) or
Table 5 MBCs (mg/L) of seven antimicrobial agents agains
planktonic bacteria and biofilms (modified from [30])
Antimicrobial
agent Planktonic Cavafix Vialon
Amikacin 2 >512 1
Clindamycin 2 >512 32
Cloxacillin 1 >512 128
Ciprofloxacin 0.5 >512 0.5
Vancomycin 4 >512 >512
Teicoplanin 16 >512 64
Daptomycin 8 >512 64
Table 4 Activity of eight antimicrobial agents against S.
epidermidis: planktonic bacteria versus biofilm on teflon
(modified from [27])
MBCbiofilm/MBC
Antimicrobial agent Slime (–) Slime (þ)
Amikacin >256 >128
Clindamycin >1024 >128
Cloxacillin >512 >256
Ciprofloxacin >1024 >256
Vancomycin >256 32
Teicoplanin >64 >16
Daptomycin >64 >32
Rifampin >32768 >8192
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rifampin (1 mg/L), against S. epidermidis biofilms
on different plastic catheters. The addition of ami-
kacin or rifampin significantly increased the activ-
ity of glycopeptides against sessile bacteria [28].
With slime-producing strains, these combinations
were able to sterilize the surface of a polyurethane
catheter (Table 6). This effect is not due to the
activity of amikacin or rifampin alone.
Resistance in the biofilm population is probably
not genetically encoded or due to the selection of
resistant bacterial subpopulations, since the resis-
tance disappears when bacteria are removed from
the catheter. Resistance is probably due to the
physiologic state of the individual cells rather than
a function of biofilm formation or slime produc-
tion [32]. Adherent bacteria grow more slowly
than planktonic bacteria as a result of the adher-
ence process rather than of nutrient depletion.
It has also been postulated that only the surface
layers of a biofilm are exposed to a lethal dose of
the antibiotic, due to a reaction–diffusion barrier
which limits the transportation of the antibiotic to
the biofilm. The absorption of the antibiotic to
biofilm components could also give rise to such
a situation [33]. In fact, the transportation proper-
ties of many antibiotics through biofilms have
been evaluated, with controversial results.
Many antimicrobial agents at subinhibitory con-
centrations have shown to inhibit slime produc-
tion and the adherence of S. epidermidis [34].
This phenomenon could theoretically be used
to prevent the adherence of bacteria to intravas-
cular catheters. Nevertheless, it has been recently
reported that the Subinhibitory Concentrations
(subMIC) of some antimicrobial agents (tetracy-
cline and streptogramins) enhanced 9–11-fold the
expression of the ica gene encoding biofilm for-
mation in S. epidermidis [35]. Other agents did not
affect ica expression.
NEW STRATEGIES IN INTRAVASCULAR
CATHETER DESIGN
Two main strategies have been employed in the
prevention of catheter-related infections: the crea-
tion of anti-adhesive biomaterials using physico-
chemical methods, and the incorporation of
antimicrobial agents into current polymer bioma-
terials [36]. The first approach must prevent not
only unspecific bacterial adhesion, but also the
adsorption of host components which promote
bacterial adhesion.
By modifying biomaterial surfaces with highly
hydrated molecules, such as heparin or polyethy-
lene oxide, anti-adhesive properties can be
obtained [37]. This kind of hydrophilic surface
has also been shown to decrease protein absorp-
tion. The development of a simple surface mod-
ification technique that creates a hydrophilic
bacterial-resistant surface has been attempted
but with limited success.
Intravascular catheters and cuffs with an anti-
microbial coating have been developed in recent
years. A silver-impregnated, subcutaneous col-
lagen cuff attached to a central venous catheter
just before insertion has been used as a tissue
interface barrier [38]. Most studies showed no
reduction in the incidence of catheter-related bac-
teremia when this cuff was used. Based on pub-
lished studies, the use of this cuff is not
recommended [39]. There is no doubt that silver
ions are active against a broad spectrum of bac-
teria. However, in an environment containing
albumin and halide ions, the antibacterial activity
of silver ions will be decreased as a result of
specific adsorption processes with albumin and
precipitation of insoluble silver chloride. Extru-
sion of the silver cuff to the skin and a reduced
subcutaneous anchorage of silver-cuffed, central
venous tunneled catheters have been reported,
possibly due to silver-induced cytotoxicity [40].
The use of heparin-bonded pulmonary catheters
has been associated with a lower risk of catheter-
related bloodstream infection. In most of these
catheters, heparin is bonded with benzalkonium
chloride, thus providing them with antimicrobial
activity [41]. According to these data, heparin-
bonded pulmonary artery catheters should beused.
The use of exidine- and silver sulfadiazine-
impregnated catheters reduces the incidence of
short-term (<2 weeks) central venous catheter-
related bloodstream infections [42]. These catheters
Table 6 Effect of glycopeptides (4MBC) alone or in
combination with amikacin or rifampicin on S. epidermidis
(slimeþ) biofilms (modified from [28])
CFU 103/catheter segment
Antimicrobial agent Teflon Polyurethane
Vancomycin 1860 3270
Teicoplanin 363 316
Vancomycinþ amikacin 0.2 242
Vancomycinþ rifampicin 0.6 0
Teicoplaninþ amikacin 3.6 0
Teicoplaninþ rifampicin 3.1 0
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have been shown to be less effective when
catheters are in place for 3 weeks or longer. This
is probably due to the lack of protection against
bacteria invading the lumen of the catheter from a
contaminated hub. Moreover, some in vitro stu-
dies have shown development of bacterial resis-
tance to clorhexidine that was sometimes extended
to other antimicrobial agents. Anaphylactic reac-
tions due to clorhexidine impregnation have also
been described [43].
Central venous catheters impregnated intra-
and extraluminally with minocycline and rifampin
have been shown to reduce the incidence of cathe-
ter-related bloodstream infection compared with
clorhexidine–silver sulfadiazine-impregnated
catheters [44]. Nevertheless, preventive strategies
should avoid the use of therapeutic antibiotics. In
fact, exposure to antimicrobial agents could favor
the development of resistance. Tetracycline at sub-
inhibitory concentrations has been shown to
increase 10-fold the expression of the ica gene
responsible for biofilm formation in S. epidermidis
[35]. On the other hand, the use of these antibiotic-
impregnated catheters could reduce the use of
systemic antibiotics for presumed or real catheter-
related infections. Before more studies are per-
formed, the use of this catheter should be restricted
to short-term central venous catheters if the rate of
infection is high despite adherence to other stra-
tegies that do not incorporate antimicrobial agents.
Future strategies include the use of catheters
with silver incorporated throughout the biomater-
ial [45]. Preliminary studies using this device
showed reduced catheter colonization. Another
possibility is the use of catheters with covalently
linked heparin on the surface, which seems to
reduce the rate of bloodstream infection [46].
Electrically charged catheters reduced catheter
colonization [47]. The production of hydrogen
peroxide and free chlorine by electrolysis at the
catheter surface avoids bacterial colonization. This
new approach is extremely interesting, since it
avoids the use of topical antimicrobial agents.
Increasing knowledge of biofilm formation will
allow new strategies for catheter design. It will be
possible to coat biomaterials with anti-adhesive
molecules,suchasantifibronectinantibodies.These
so-called ‘biospecific polymers’ will certainly
reduce catheter colonization by specific microor-
ganisms. The use of agents which might block
the messengers involved in quorum-sensing-
dependent biofilm formation may also be possible.
Future methods blocking the expression of genes
controlling S. epidermidis adherence to biomaterials
could prevent this type of infection [39].
In conclusion, better knowledge of the patho-
genesis of catheter-related infections will facilitate
the design of new devices that avoid the use of
antimicrobial agents and decrease the risk of asso-
ciated bloodstream infections.
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